Weight
Loss.
Evidence-led reading on weight loss from the HL Benefits desk. Long reads, careful guides, and the boring-but-true positions the research keeps settling on.
How Long Do You Stay on GLP-1 Drugs? The Lifetime Question
The WHO recommends long-term GLP-1 use for obesity. But only 4-year data exists, and half of patients stop by year one. What the research says about the forever drug question.
Photograph · HL BenefitsThe latest, in long form.
Browse all 39 →
Your First Month on Ozempic: A Week-by-Week Guide
A week-by-week breakdown of your first month on Ozempic, covering dose titration, side effect management, eating strategies, and when to call your doctor.
Amycretin: The GLP-1 + Amylin Drug Showing 25%+ Weight Loss
Weight LossCagriSema: Novo Nordisk's Next-Generation Obesity Drug Explained
Weight LossPeptides for Stubborn Menopausal Belly Fat: The Tesamorelin Conversation Continues
Why Compounded Peptides Cost 80% Less Than Brand-Name GLP-1s
The same semaglutide molecule, 80% less. Here's where every dollar goes and why the price gap is shrinking.
Weight Loss Peptides After 50: What Changes for Women in Perimenopause
Tirzepatide and semaglutide produce nearly identical weight loss across reproductive stages. Pairing GLP-1 peptides with HRT increases loss by ~30%.
Why Tirzepatide Users Lose 22% of Their Body Weight — and What Happens When They Stop
Tirzepatide drives an average 22.5% body-weight loss in trials — but stopping the drug leads to roughly 14% regain in a year, even with diet and exercise.
We started this section because the conversation about weight loss had become unbearable — too loud, too certain, too often selling something. The boring middle — what the evidence actually supports, repeated across decades, written without a brand to defend — is not a position you can monetize, but it is the position the research keeps quietly settling on.
Companion sections.
All sections →Health
A companion section to weight loss, with its own evidence-led reading list.
Food & Nutrition
A companion section to weight loss, with its own evidence-led reading list.
Fitness
A companion section to weight loss, with its own evidence-led reading list.
Definitive guides.
All guides →
The GLP-1 Side Effect List Your Doctor Probably Won't Mention
Most patients on Ozempic, Wegovy, or Zepbound hear about nausea and stop there. The full safety profile includes lean muscle loss, sulfur burps, gallstones, NAION vision risk, anesthesia warnings,…
Liraglutide vs. Semaglutide vs. Tirzepatide: A Plain-English Comparison Chart
How the three big GLP-1 drugs really compare on weight loss, cardiovascular benefit, dosing schedule, side effects, and cost.
A claim about weight loss is not a study. A study is not a meta-analysis. A meta-analysis is not a guideline. The article doesn't fit on a label.
On our desk this week.
More from the desk →
Tirzepatide vs. Semaglutide: Which GLP-1 Peptide Actually Melts More Fat?
SURMOUNT-5 settled the indirect-comparison era. Here is what the head-to-head trial actually showed about tirzepatide versus semaglutide for fat loss.
The 7 Most Effective Weight Loss Peptides Doctors Are Quietly Recommending in 2026
From semaglutide to retatrutide and tesamorelin: the seven peptides reshaping obesity care, what trials really show, and what to ask before starting.
Quick reads.
All 39 →Compounded Semaglutide: How to Tell a Safe Source from a Dangerous Knockoff
After the FDA declared the semaglutide shortage resolved in February 2025, the legal…
AOD-9604: The 'Fat-Burning Fragment' That Promises Results Without Hunger Loss
AOD-9604 is sold as fat loss without hunger. The 24-week trial in 536 people that was…
Tirzepatide vs Semaglutide (Mounjaro/Zepbound vs Ozempic/Wegovy): Complete Comparison
SURMOUNT-5 trial data comparing tirzepatide and semaglutide head-to-head, with…
Retatrutide: The Triple-Agonist Weight Loss Drug Showing 24-29% Body Weight Reduction
Retatrutide achieved 28.7% weight loss in Phase 3 trials -- matching bariatric surgery…
Oral Semaglutide (Rybelsus / Wegovy Pill): The End of Weight Loss Injections?
The FDA approved the first oral GLP-1 for weight loss in December 2025. Clinical trials…
Ozempic Face: Why It Happens, How to Prevent It, and Treatment Options
Facial volume loss from rapid GLP-1 weight loss affects millions. Evidence-based…
The Gelatin Trick for Weight Loss: Does Science Support This Viral Hack?
Research shows gelatin suppresses appetite 44% more than casein short-term, but…
How to Prevent Muscle Loss on GLP-1 Medications
Evidence-based strategies to preserve muscle mass on semaglutide and tirzepatide,…
From the archive.
All 39 →
How Cortisol Drives Weight Gain and What Actually Helps
CLA Safflower Oil Reviews: What the Research Actually Shows
Weight Loss Supplements for Women Over 40: What the Research Says
Do Keto Diet Pills Actually Burn Fat? The Science Behind Exogenous Ketones
Natural Fat Burners: Evidence-Based Strategies for Sustainable Weight Loss
An evidence-based guide to natural fat burners including berberine, green tea extract, and capsaicinoids, with honest comparisons to GLP-1 medications.
GLP-1 Drugs, Celebrity Bodies, and the Ethics of Modern Weight Loss
What you should know about GLP-1 drugs, their real risks, and why celebrity culture makes the conversation harder.
GLP-1 Muscle Sparing Protocol: What Actually Works
GLP-1 therapy can cause significant muscle loss. Discover evidence-based protocols using protein, resistance training, and supplements to protect lean mass.
Nature-Identical GLP-1 Support: What Actually Works
A practical, evidence-based guide to natural GLP-1 support with food strategy, sleep timing, and safety warnings on unapproved products.
Can Yoga Help With Weight Loss?
